DAgnano V, Scialo F, Perna F, Atripaldi L, Sanduzzi S, Allocca V
Life (Basel). 2022; 12(8).
PMID: 36013321
PMC: 9409731.
DOI: 10.3390/life12081141.
Campo I, Meloni F, Gahlemann M, Sauter W, Ittrich C, Schoelch C
Sci Rep. 2022; 12(1):8708.
PMID: 35610268
PMC: 9130212.
DOI: 10.1038/s41598-022-11446-8.
Lillehoj E, Luzina I, Atamas S
Front Immunol. 2022; 13:883079.
PMID: 35479093
PMC: 9035539.
DOI: 10.3389/fimmu.2022.883079.
Naderi N, Rahimzadeh M
Virology. 2021; 566:106-113.
PMID: 34896901
PMC: 8642780.
DOI: 10.1016/j.virol.2021.11.006.
Sato S, Kato T, Abe K, Hanaoka T, Yano Y, Kurosaki A
Oncol Lett. 2017; 14(1):776-786.
PMID: 28693233
PMC: 5494608.
DOI: 10.3892/ol.2017.6254.
Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer.
Tomita M, Ayabe T, Chosa E, Nose N, Nakamura K
Asian Pac J Cancer Prev. 2017; 18(1):287-291.
PMID: 28240848
PMC: 5563114.
DOI: 10.22034/APJCP.2017.18.1.287.
Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.
Tomita M, Ayabe T, Chosa E, Nose N, Nakamura K
Gen Thorac Cardiovasc Surg. 2016; 64(11):657-661.
PMID: 27515028
DOI: 10.1007/s11748-016-0706-4.
MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.
Bonella F, Xiaoping Long , Ohshimo S, Horimasu Y, Griese M, Guzman J
Orphanet J Rare Dis. 2016; 11:48.
PMID: 27108412
PMC: 4841967.
DOI: 10.1186/s13023-016-0430-2.
The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.
de Wit S, van Dalum G, Lenferink A, Tibbe A, Hiltermann T, Groen H
Sci Rep. 2015; 5:12270.
PMID: 26184843
PMC: 4505332.
DOI: 10.1038/srep12270.
Update on therapeutic management of idiopathic pulmonary fibrosis.
Tzouvelekis A, Bonella F, Spagnolo P
Ther Clin Risk Manag. 2015; 11:359-70.
PMID: 25767391
PMC: 4354471.
DOI: 10.2147/TCRM.S69716.
Serum heat shock protein 47 levels are elevated in acute interstitial pneumonia.
Kakugawa T, Yokota S, Ishimatsu Y, Hayashi T, Nakashima S, Hara S
BMC Pulm Med. 2014; 14:48.
PMID: 24650086
PMC: 3994423.
DOI: 10.1186/1471-2466-14-48.
Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis.
Bonella F, Ohshimo S, Miaotian C, Griese M, Guzman J, Costabel U
Orphanet J Rare Dis. 2013; 8:53.
PMID: 23557396
PMC: 3629718.
DOI: 10.1186/1750-1172-8-53.
KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome.
Kida Y, Ohshimo S, Ota K, Tamura T, Otani T, Une K
Orphanet J Rare Dis. 2012; 7:99.
PMID: 23244165
PMC: 3551709.
DOI: 10.1186/1750-1172-7-99.
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K
Am J Respir Crit Care Med. 2011; 183(6):788-824.
PMID: 21471066
PMC: 5450933.
DOI: 10.1164/rccm.2009-040GL.
KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome.
Kondo T, Hattori N, Ishikawa N, Murai H, Haruta Y, Hirohashi N
Respir Res. 2011; 12:32.
PMID: 21418654
PMC: 3068089.
DOI: 10.1186/1465-9921-12-32.
Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody.
Matsumura K, Niki I, Tian H, Takuma M, Hongo N, Matsumoto S
Radiat Med. 2008; 26(3):133-9.
PMID: 18683568
DOI: 10.1007/s11604-007-0207-6.
Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome.
Nathani N, Perkins G, Tunnicliffe W, Murphy N, Manji M, Thickett D
Crit Care. 2008; 12(1):R12.
PMID: 18269741
PMC: 2374609.
DOI: 10.1186/cc6785.
Anti-tumor effect of the anti-KL-6/MUC1 monoclonal antibody through exposure of surface molecules by MUC1 capping.
Doi M, Yokoyama A, Kondo K, Ohnishi H, Ishikawa N, Hattori N
Cancer Sci. 2006; 97(5):420-9.
PMID: 16630141
PMC: 11158332.
DOI: 10.1111/j.1349-7006.2006.00183.x.
Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.
Gad A, Tanaka E, Matsumoto A, Wahab M, Serwah A, Attia F
World J Gastroenterol. 2006; 11(42):6607-12.
PMID: 16425352
PMC: 4355752.
DOI: 10.3748/wjg.v11.i42.6607.
Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.
Kitaichi N, Ariga T, Kase S, Yoshida K, Namba K, Ohno S
Graefes Arch Clin Exp Ophthalmol. 2005; 244(4):433-7.
PMID: 16133026
DOI: 10.1007/s00417-005-0081-9.
